Close
Back to CEMI Stock Lookup
Pages: 1 2 3 »» Last Page

Chembio Diagnostics (CEMI) – StreetInsider.com Reports

Apr 3, 2023 04:18 PM Chembio Diagnostics' (CEMI) CEO Letter to Stockholders
Feb 24, 2023 08:01 AM Chembio Diagnostics (CEMI) Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
Jan 31, 2023 05:00 PM Chembio Diagnostics (CEMI) Acquired by Biosynex for $0.45/sh
Jan 31, 2023 04:56 PM Chembio Diagnostics (CEMI) Halted, News Pending
Nov 28, 2022 08:04 AM Chembio Diagnostics (CEMI) Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System
Sep 6, 2022 08:09 AM Chembio Diagnostics (CEMI) Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay
Sep 1, 2022 12:18 PM Chembio Diagnostics (CEMI) awarded a $3.25m CDC contract
Aug 22, 2022 12:47 PM Chembio Diagnostics (CEMI) on Watch on Department of Agriculture News
May 24, 2022 04:17 PM Chembio Diagnostics (CEMI) Appoints Leslie Teso-Lichtman to its Board
Jan 5, 2022 04:05 PM Chembio Diagnostics (CEMI) Appoints Larry Steenvoorden as CFO
Dec 6, 2021 08:08 AM Chembio Diagnostics (CEMI) Submits FDA De Novo/510(k) Request for DPP SARS-CoV-2 Antigen Test System
Nov 17, 2021 09:24 AM Pre-Open Stock Movers 11/17: (AVGR) (RMTI) (VRAR) Higher; (SAVA) (AVIR) (STNE) Lower (more...)
Nov 16, 2021 05:43 PM After-Hours Stock Movers 11/16: (CEMI) (LZB) (VREX) Higher; (AVIR) (STNE) (DLB) Lower (more...)
Nov 16, 2021 04:06 PM Chembio Diagnostics (CEMI) Submits EUA Application for New DPP SARS-CoV-2 Antigen Test
Sep 22, 2021 08:01 AM Chembio Diagnostics (CEMI) Announces EUA Submission for DPP Respiratory Antigen Panel
Aug 30, 2021 02:12 AM Increasing unusual call option volume: EWJ CEMI ATER HP SLQT BBIG
Aug 27, 2021 10:27 AM Increasing unusual call option volume: CEMI OPRX SLQT WDAY BILL SOAC
Aug 27, 2021 08:01 AM Chembio Diagnostics (CEMI) Announces Commercial Distribution of Third-Party COVID-19 Antigen Assay
Aug 3, 2021 01:28 PM Chembio Diagnostics (CEMI) Gains Said Tied to EUA for Partner
Jul 21, 2021 02:33 PM Colliers Securities Downgrades Chembio Diagnostics (CEMI) to Hold
Jul 21, 2021 09:20 AM Pre-Open Stock Movers 07/21: (CEMI) (LE) (SDC) Higher; (SNBR) (FOUR) (MGTA) Lower (more...)
Jul 21, 2021 05:19 AM Chembio Diagnostics (CEMI) Announces $28.3M Order for DPP SARS-CoV-2 Antigen Tests in Brazil
Apr 5, 2021 06:29 AM Chembio Diagnostics (CEMI) Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu (earlier)
Mar 8, 2021 08:03 AM Chembio Diagnostics (CEMI) Announces David Bespalko to Board
Dec 3, 2020 07:03 AM Craig-Hallum Upgrades Chembio Diagnostics (CEMI) to Buy
Dec 2, 2020 01:24 PM Chembio Diagnostics (CEMI) Awarded $12.7 Million by BARDA for Rapid DPP SARS-CoV-2 Antigen Test System
Nov 6, 2020 08:16 AM Colliers Securities Upgrades Chembio Diagnostics (CEMI) to Buy
Oct 2, 2020 07:27 AM Chembio Diagnostics (CEMI) Receives FDA Approval for DPP HIV-Syphilis System
Aug 12, 2020 01:09 PM Chembio Diagnostics (CEMI) partner LumiraDX gets FDA Emergency Use Authorization for its LumiraDx SARS-CoV-2 RNA STAR test
Jul 6, 2020 04:23 PM Chembio Diagnostics (CEMI) sees Q2 revenue of $4.5 million to $4.7 million
Jul 6, 2020 04:13 PM Chembio Diagnostics (CEMI) Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System
Jul 6, 2020 04:13 PM Chembio Diagnostics (CEMI) to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen System
Jul 6, 2020 10:47 AM Chembio Diagnostics (CEMI) awarded a $628K HHS contract for research and development of a SARS-COV-2 AG System
Jun 17, 2020 11:34 AM Chembio Diagnostics (CEMI) Cut in Half After FDA Revokes EUA for its COVID-19 Serological Test Due to 'Performance Concerns'
Jun 17, 2020 09:27 AM Pre-Open Movers 06/17: (WATT) (INWK) (GRPN) Higher; (CEMI) (ATNM) (NCLH) Lower (more...)
Jun 17, 2020 09:13 AM Baird Downgrades Chembio Diagnostics (CEMI) to Neutral
Jun 17, 2020 08:33 AM Chembio Diagnostics (CEMI) PT Lowered to $8 at Craig-Hallum
Jun 17, 2020 07:34 AM Colliers Securities Downgrades Chembio Diagnostics (CEMI) to Hold
Jun 17, 2020 07:19 AM Craig-Hallum Downgrades Chembio Diagnostics (CEMI) to Hold
Jun 17, 2020 06:21 AM Benchmark Downgrades Chembio Diagnostics (CEMI) to Hold
Jun 17, 2020 05:33 AM Canaccord Genuity Downgrades Chembio Diagnostics (CEMI) to Hold as FDA Revoked EUA
Jun 8, 2020 08:05 AM Chembio Diagnostics (CEMI) Receives FDA 510(k) Clearance for DPP Zika IgM System
May 26, 2020 06:30 AM Baird Starts Chembio Diagnostics (CEMI) at Outperform
May 18, 2020 12:30 PM Chembio Diagnostics (CEMI) PT Raised to $22 at Canaccord Genuity
May 18, 2020 07:02 AM Chembio Diagnostics (CEMI) Announces US Distribution Agreement to Expand Reach of DPP COVID-19 Serological Test with Thermo Fisher Scientific’s Healthcare Channel
May 7, 2020 08:56 AM Chembio Diagnostics (CEMI) Prices 2.34M Common Stock Offering at $11.75/sh
May 6, 2020 05:32 PM Chembio Diagnostics (CEMI) to Offer Common Stock
Apr 23, 2020 09:26 AM Chembio Diagnostics (CEMI) PT Raised to $21 at Craig-Hallum
Apr 16, 2020 12:01 PM Chembio Diagnostics (CEMI) Ramps Following FDA Approval for Point-of-Care COVID-19 Test
Apr 16, 2020 08:21 AM Chembio Diagnostics (CEMI) PT Raised to $12 at Canaccord Genuity
Pages: 1 2 3 »» Last Page

Back to CEMI Stock Lookup